These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11888907

  • 1. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
    Raghow S, Hooshdaran MZ, Katiyar S, Steiner MS.
    Cancer Res; 2002 Mar 01; 62(5):1370-6. PubMed ID: 11888907
    [Abstract] [Full Text] [Related]

  • 2. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K.
    Carcinogenesis; 2005 Jun 01; 26(6):1109-16. PubMed ID: 15731164
    [Abstract] [Full Text] [Related]

  • 4. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
    Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M.
    J Urol; 2006 Sep 01; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
    [Abstract] [Full Text] [Related]

  • 5. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P, Lindahl C, Bergh A.
    Prostate; 2005 Feb 01; 62(2):148-64. PubMed ID: 15389804
    [Abstract] [Full Text] [Related]

  • 7. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 8. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice.
    Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP, Zheng J.
    Eur J Cancer Prev; 2009 Aug 15; 18(4):331-41. PubMed ID: 19444125
    [Abstract] [Full Text] [Related]

  • 9. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD, Zakrajsek BA, Hill RE, Liu Q, Reeves JJ, Axford PD, Singer MJ, Reed MW.
    Prostate; 2003 Jun 01; 55(4):308-16. PubMed ID: 12712410
    [Abstract] [Full Text] [Related]

  • 10. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.
    Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639
    [Abstract] [Full Text] [Related]

  • 11. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A.
    Cancer Res; 2001 Sep 15; 61(18):6777-82. PubMed ID: 11559550
    [Abstract] [Full Text] [Related]

  • 12. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM.
    Cancer Res; 1997 Nov 01; 57(21):4687-91. PubMed ID: 9354422
    [Abstract] [Full Text] [Related]

  • 13. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [Abstract] [Full Text] [Related]

  • 14. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.
    Cancer Res; 2001 Oct 15; 61(20):7449-55. PubMed ID: 11606379
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.
    J Clin Oncol; 2013 Feb 10; 31(5):523-9. PubMed ID: 23295793
    [Abstract] [Full Text] [Related]

  • 16. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K, Singh RP, Agarwal R, Agarwal C.
    Cancer Res; 2007 Jun 15; 67(12):5976-82. PubMed ID: 17575168
    [Abstract] [Full Text] [Related]

  • 17. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
    Wechter WJ, Leipold DD, Murray ED, Quiggle D, McCracken JD, Barrios RS, Greenberg NM.
    Cancer Res; 2000 Apr 15; 60(8):2203-8. PubMed ID: 10786685
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.
    J Urol; 2005 May 15; 173(5):1778-83. PubMed ID: 15821586
    [Abstract] [Full Text] [Related]

  • 19. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM.
    Cancer Res; 1997 Aug 15; 57(16):3325-30. PubMed ID: 9269988
    [Abstract] [Full Text] [Related]

  • 20. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL, Xie Z, Yu J, Martin WD, Datta MW, Wu GJ, Chung LW.
    Prostate; 2007 May 15; 67(7):685-91. PubMed ID: 17342752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.